Amedisys, Inc., one of America's leading home health and hospice companies, today announced that executives from Amedisys will present at two upcoming conferences. The first presentation will be at the Robert W. Baird & Company 2010 Health Care Conference in New York, NY on Tuesday, September 14, 2010.
Last Frontier in Patient Monitoring Now Conquered: Noninvasive and Continuous Temperature Monitoring Has Arrived. Brain Tunnelgenix Technologies Corp. announced today that the U.S. Food and Drug Administration has granted the company clearance to market its Abreu BTT 700 System for continuous temperature monitoring.
ALISO VIEJO, Calif., Sept. 9 Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today announced that the Company's presentation time at the Baird 2010 Health Care Conference has changed to 9:00 am EDT on Tuesday, September 14, 2010.
WOONSOCKET, R.I., Sept. 9 CVS Caremark today said that ongoing research into how behavioral economics impacts health care choices found that when consumers are presented with a clear and active choice in a voice-recorded message to select automatic prescription refills, rather than a passive default notification, they are twice as likely to choose
PRINCETON, N.J., Sept. 9 New Jersey is a model of diversity. But a state rich in diversity also faces healthcare challenges. With that landscape as a backdrop, the State of New Jersey has declared September Minority and Multicultural Health Month. "Cookie-cutter healthcare won't cut it in a state as diverse as New Jersey," said NJHA President and C
Agency cites unsubstantiated claims, poor manufacturing practices. SILVER SPRING, Md., Sept. 9 The U.S. Food and Drug Administration today issued warning letters to five distributors for various violations of the Federal Food, Drug, and Cosmetic Act including unsubstantiated claims and poor manufacturing practices.
To: HEALTH, MEDICAL, AND NATIONAL EDITORS. Contact: Sandy Walsh of FDA, +1-301-796-4669, sandy.walsh@fda.hhs.gov. The U.S. Food. and Drug Administration has approved the pediatric use of Protopam. Chloride, a drug used to treat poisoning by. organophosphate pesticides and chemicals. The. drug is approved to be administered either by intravenous or.
To: HEALTH, AND NATIONAL EDITORS. Contact: Siobhan DeLancey of the U.S. Food and Drug Administration, +1-301-796-4668, siobhan.delancey@fda.hhs.gov. Agency cites unsubstantiated claims, poor manufacturing practices. The U.S. Food. and Drug Administration today issued warning letters to five. distributors for various violations of the Federal Food,
FDA NEWS RELEASE. FDA approves pediatric use of chemical poisoning treatment. The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride, a drug used to treat poisoning by organophosphate pesticides and chemicals.
ATLANTA, Sept. 9 Gentiva Health Services, Inc., the nation's largest provider of home health and hospice services, announced today that it will present at the Baird 2010 Health Care Conference in New York at 8:30 a.m. ET on Wednesday, September 15, 2010 and the Stifel Nicolaus 2010 Health Care Conference in Boston at 2:05 p.m. ET on Thursday, Septe
New App for iPhone and iPod touch Allows Members to Connect to Their Accounts, Conduct Business and Quickly Access Vital Information. Members of Health Net, Inc. now have mobile access to their accounts and other key details - like maps and directions to their nearest urgent care center - providing on-the-go capabilities to conduct business and qui
Hospira, Inc., a leading provider of clinical information and medication delivery technologies, and Smiths Medical, a leading global medical device manufacturer, today announced a commercial collaboration and co-development agreement for infusion pump systems.
MONTEREY, Calif., Sept. 9 Language Line Services, the leading provider of language-based solutions and the number one provider of over-the-phone interpreting services for the healthcare industry, announced a program of support, instructional materials and consultations to help ensure compliance for hospitals as they gear up for the new Joint Commis
To: HEALTH, AND STATE EDITORS. Contact: Kerry McKean Kelly, New Jersey Hospital Association, +1-609-275-4069, kmckean@njha.com. New Jersey is a. model of diversity. nations, and the U.S. Census Bureau ranks the Garden State third in. the nation in the percentage of foreign-born residents. But a state rich in diversity also faces healthcare challeng
Healthcare supplier Perrigo Company declared on Wednesday the receipt of approval from the US Food and Drug Administration to manufacture and market Imiquimod Cream, 5%. The company said it will vertically integrate Imiquimod Cream, 5% with its own API.
A new study, 'Sunlight robbery: a critique of public health policy on vitamin D in the UK,' is now available. "Few food products are fortified with vitamin D in the UK and the government does not recommend any vitamin D supplement for most adults in the UK.
SYSPRO, the leading provider of visionary, pragmatic ERP software, announced that the company is highly confident that the SYSPRO ERP solution will enable pharmaceutical manufacturers to meet the new U.S. Food and Drug Administration regulations being proposed by Congress. Traceability functionality is the key component required to assist in the me
Tenet Healthcare Corporation today announced that Trevor Fetter, Tenet's president and chief executive officer, and Biggs C. Porter, chief financial officer, will speak at the Morgan Stanley Global Healthcare Conference in New York on September 14, 2010 at 8:35 AM. Tenet's remarks will be available live by webcast and may be accessed through the in
Alexion Pharmaceuticals, Inc. announced that the US Food and Drug Administration has approved Alexion's Rhode Island manufacturing facility in Smithfield, Rhode Island as a second source of commercial supply for Soliris. Earlier this year, Alexion reported that the European Medicines Agency had approved ARIMF as a second source of supply for Soli
Item 8.01. On September 8, 2010, BioMimetic Therapeutics, Inc. issued a press release that announced it completed its 100 day Premarket Approval Application meeting with the Food and Drug Administration regarding the review of Augment Bone Graft for the treatment of foot and ankle fusions in the United States. The Company continues to anticipate th
Columbus, Ind. Columbus Regional Hospital is bringing the nation's largest health information exchange to the Columbus, Ind. area to better serve patients.
WOONSOCKET, R.I., Sept. 8 CVS Caremark announced today that it will partner with Direct Relief USA to offer up to $5 million in free flu shots to community clinic and health center patients who lack health insurance. Flu vaccinations are now available at all CVS/pharmacy and MinuteClinic locations nationwide.
NEW YORK, Sept. 8 Delcath Systems, Inc. announced today that management will present at CL King's 8th Annual Best Ideas Conference on Wednesday, September 15, 2010 at 10:00 a.m. ET in New York, NY. Mr. David McDonald, Chief Financial Officer, will provide an overview of the Company's business strategy and recent corporate developments. Attendance
WEST CHESTER, PA, Sept. 8 DiagnoCure Oncology Laboratories, the U.S. subsidiary of DiagnoCure, Inc., announced that Valerie Palmieri, President of the U.S. operation, will present an overview of the laboratory's plans for a colorectal cancer disease management program at the Rodman & Renshaw Annual Global Investment Conference on Wednesday, Septemb
Pharmaceutical company Forest Laboratories Inc revealed on Tuesday that a US Food and Drug Administration advisory committee has recommended approval of the companyEURs ceftaroline fosamil for the treatment of community acquired bacterial pneumonia and complicated skin and skin structure infections.
